SPRY
Ars Pharmaceuticals Inc
2 of the 83 super-investors we track hold SPRY, worth a combined $12M per their latest 13F filings. The largest position: Daniel Loeb at 0.2% of their portfolio. No cohort buying or selling was filed on the name this quarter. Conviction score: 18 of 100 (how strongly the cohort backs it) — ranked #677 of 742 stocks.
Why super-investors own SPRY
SPRY is held by 2 super-investors in our cohort, with a combined position value of $12M. The highest-conviction owner is Daniel Loeb at 0.2% of their portfolio. Cohort ownership has grown from 1 to 2 over the last four quarters — net interest is rising.
AI-synthesized from 13F filings. Not investment advice.
Cohort owners over time
2020Q4 → 2026Q2How many of the cohort members held this stock each quarter.
Owners (2) · click any column to sort
| #↑ | Manager | % Port. | History | Value | Shares |
|---|---|---|---|---|---|
| 1 | Daniel Loeb | 0.2% | 3q | $8M | 1,000,000 |
| 2 | Joel Greenblatt | <0.1% | 22q | $4M | 531,063 |
Owners of SPRY also hold
Long US equity 13F-HR filings only. CUSIP 82835W108. Not investment advice.